+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975



Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975



Annals of Oncology 17(11): 1698-1704



The aim of this prognostic factor analysis was to investigate if a patient's self-reported health-related quality of life (HRQOL) provided independent prognostic information for survival in non-small cell lung cancer (NSCLC) patients. Pretreatment HRQOL was measured in 391 advanced NSCLC patients using the EORTC QLQ-C30 and the EORTC Lung Cancer module (QLQ-LC13). The Cox proportional hazards regression model was used for both univariate and multivariate analyses of survival. In addition, a bootstrap validation technique was used to assess the stability of the outcomes. The final multivariate Cox regression model retained four parameters as independent prognostic factors for survival: male gender with a hazard ratio (HR) = 1.32 (95% CI 1.03-1.69; P = 0.03); performance status (0 to 1 versus 2) with HR = 1.63 (95% CI 1.04-2.54; P = 0.032); patient's self-reported score of pain with HR= 1.11 (95% CI 1.07-1.16; P < 0.001) and dysphagia with HR = 1.12 (95% CI 1.04-1.21; P = 0.003). A 10-point shift worse in the scale measuring pain and dysphagia translated into an 11% and 12% increased in the likelihood of death respectively. A risk group categorization was also developed. The results suggest that patients' self-reported HRQOL provide independent prognostic information for survival. This finding supports the collection of such data in routine clinical practice.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049412433

Download citation: RISBibTeXText

PMID: 16968876

DOI: 10.1093/annonc/mdl183


Related references

Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients. European Journal of Cancer 52: 120-128, 2016

Pretreatment prognostic factors for survival in non-small-cell lung cancer: A multivariate analysis of 229 patients. Onkologie 21(3): 204-210, 1998

Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer ? A multivariate prognostic factor analysis of 151 patients. Journal of Thoracic and Cardiovascular Surgery 106(1): 90-94, 1993

Baseline quality of life (QOL) as a prognostic factor for overall survival (OS) in patients (Pts) with advanced stage non-small cell lung cancer (A-NSCLC): An analysis of NCCTG studies. Journal of Clinical Oncology 26(15_Suppl): 8076-8076, 2016

Prognostic factors for survival in inoperable non-small-cell lung cancer: A multivariate regression analysis of 456 patients with radiation therapy. Onkologie 20(2): 126-131, 1997

Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. Journal of Clinical Oncology 27(1): 78-84, 2009

Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients. Annals of Oncology 8(6): 547-553, 1997

Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer. Journal of Thoracic Oncology 4(9): 1075-1082, 2009

Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. Journal of Clinical Oncology 25(36): 5731-5737, 2007

Prognostic factors with a multivariate analysis for survival pfas in advanced non small cell lung cancer overview of experience of the european lung cancer working party. Proceedings of the American Association for Cancer Research Annual Meeting 32: 190, 1991

Multivariate analysis of prognostic factors in patients with small cell lung cancer. Zhongguo Fei Ai Za Zhi 9(6): 525-529, 2006

A multivariate analysis of prognostic factors for health-related quality of life in patients with surgically managed meningioma. Journal of Clinical Neuroscience 17(4): 446-449, 2010

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. Journal of Clinical Oncology 13(5): 1221-1230, 1995

Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer. Health and Quality of Life Outcomes 14: 52, 2016

Multivariate analysis of prognostic factors in the eldly patients with small cell lung cancer: a study of 160 patients. Zhongguo Fei Ai Za Zhi 17(1): 15-23, 2014